Ken Griffin Stereotaxis, Inc. Transaction History

Citadel Advisors LLC

$559 Billion
Q4 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Stereotaxis, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 32,700 shares of STXS stock, worth $71,613. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,700

Previous 1,800 1716.67%

Holding current value

$71,613

Previous $3,000 2366.67%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$1.84 - $2.47 $19,200 - $25,774	10,435 Added 19.21%	64,752 $147,000
Q3 2024 Nov 14, 2024	SELL	$1.76 - $2.35 $35,189 - $46,985	-19,994 Reduced 26.91%	54,317 $110,000
Q2 2024 Aug 14, 2024	BUY	$1.73 - $3.2 $5,928 - $10,966	3,427 Added 4.83%	74,311 $135,000
Q1 2024 May 15, 2024	SELL	$1.74 - $3.16 $90,721 - $164,759	-52,139 Reduced 42.38%	70,884 $185,000
Q4 2023 Feb 14, 2024	SELL	$1.42 - $1.96 $40,001 - $55,213	-28,170 Reduced 18.63%	123,023 $215,000
Q3 2023 Nov 14, 2023	SELL	$1.42 - $1.84 $31,639 - $40,997	-22,281 Reduced 12.84%	151,193 $238,000
Q2 2023 Aug 14, 2023	SELL	$1.51 - $2.27 $28,594 - $42,986	-18,937 Reduced 9.84%	173,474 $265,000
Q1 2023 May 15, 2023	SELL	$1.85 - $2.71 $8,972 - $13,143	-4,850 Reduced 2.46%	192,411 $392,000
Q4 2022 Feb 14, 2023	BUY	$1.55 - $2.38 $188,896 - $290,048	121,869 Added 161.65%	197,261 $408,000
Q3 2022 Nov 14, 2022	SELL	$1.75 - $2.62 $418,313 - $626,274	-239,036 Reduced 76.02%	75,392 $136,000
Q2 2022 Aug 15, 2022	BUY	$1.75 - $3.71 $352,990 - $748,340	201,709 Added 178.95%	314,428 $578,000
Q1 2022 May 16, 2022	SELL	$3.11 - $6.63 $215,812 - $460,075	-69,393 Reduced 38.1%	112,719 $420,000
Q4 2021 Feb 14, 2022	SELL	$5.14 - $6.84 $224,525 - $298,784	-43,682 Reduced 19.35%	182,112 $1.13 Million
Q3 2021 Nov 15, 2021	BUY	$5.34 - $9.87 $833,568 - $1.54 Million	156,099 Added 223.97%	225,794 $1.22 Million
Q2 2021 Aug 16, 2021	BUY	$6.41 - $10.17 $150,750 - $239,178	23,518 Added 50.93%	69,695 $671,000
Q1 2021 May 17, 2021	BUY	$4.43 - $7.95 $99,245 - $178,103	22,403 Added 94.23%	46,177 $310,000
Q4 2020 Feb 16, 2021	BUY	$3.11 - $5.3 $73,937 - $126,002	23,774 New	23,774 $121,000
Q3 2020 Nov 16, 2020	SELL	$3.18 - $4.57 $66,039 - $94,905	-20,767 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$2.71 - $5.47 $56,278 - $113,595	20,767 New	20,767 $93,000

Others Institutions Holding STXS

# of Institutions

Shares Held

41.8M

Call Options Held

217K

Put Options Held

4.1K

View Full List

About Stereotaxis, Inc.

Ticker STXS
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,790,096
Market Cap $164M
Description
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...

More about STXS

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account